PHARMACEUTICAL DOSAGE FORMS CONTAINING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLATE

World Intellectual Property Organization Patent

APP PUB NO WO-2015055564-A1
SERIAL NO

PCTEP2014071855

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to solid pharmaceutical dosage forms that can be orally administered, containing sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate (active ingredient (I)), characterized in that the active ingredient (I) is released. The invention further relates to methods for producing said dosage forms, to the use of said dosage forms as drugs, and to the use of said dosage forms for the prophylaxis, secondary prophylaxis, or treatment of diseases, in particular cardiovascular diseases, cardiac insufficiency, anemia, chronic kidney diseases, and renal failure.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AGDELEVERKUSEN GERMANY LEVERKUSEN NORTH RHINE-WESTPHALIA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address
BENKE KLAUS BERGISCH GLADBACH
NEUMANN HEIKE WUPPERTAL
FORMELL MICHAEL GLIENICKE
WINTER GABRIELE GLIENICKE

Cited Art Landscape

Load Citation